PLAUR and neuroendocrine neoplasm: Moreover, our recent work has revealed a high correlation between uPAR expression on uPAR-PET and both overall survival (OS) and progression-free survival (PFS) in patients with neuroendocrine neoplasms underscoring uPAR as a promising target for PRRT treatment.